Skip to main content
Livermore
Livermore
ZHEN

MBX Biosciences, Inc.

MBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001776111

In the last 90 days, MBX Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 172 institutions reported holding it in 13F filings for Q2 2026, worth $3.06B in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding MBX Biosciences, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of MBX: Q2 2024 compared with Q3 2024
MeasureQ2 2024Q3 2024Change
Holders045+45
Shares030.3M+30.3M
Value$0$784.1M+$784.1M

New holders (45)

Institutions that held MBX Biosciences, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to MBX in Q3 2024
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.5,985,347$155.5M6.23%
OrbiMed Advisors LLC3,812,215$99.0M1.81%
NEA Management Company, LLC3,614,486$93.9M5.12%
Deep Track Capital, LP3,018,935$78.4M2.50%
Wellington Management Group LLP2,937,853$74.3M0.01%
NVP Associates, LLC2,136,335$55.5M31.51%
Ra Capital Management, L.P.1,511,334$39.3M0.45%
Price T Rowe Associates Inc1,192,938$31.0M0.00%
EcoR1 Capital, LLC1,175,809$30.5M1.05%
Driehaus Capital Management LLC981,322$25.5M0.22%
Cormorant Asset Management, LP700,000$18.2M0.96%
TCG Crossover Management, LLC650,000$16.9M1.43%
Woodline Partners LP519,675$13.5M0.11%
Millennium Management LLC440,411$11.4M0.01%
Franklin Resources Inc450,000$10.6M0.00%
Alyeska Investment Group, L.P.225,000$5.85M0.03%
Platinum Investment Management Ltd150,000$3.90M0.18%
Citadel Advisors LLC135,608$3.52M0.00%
Goldman Sachs Group Inc51,000$1.32M0.00%
Vanguard Group Inc50,000$1.30M0.00%
Monashee Investment Management LLC50,000$1.30M0.14%
Maven Securities LTD50,000$1.30M0.15%
StemPoint Capital LP50,000$1.30M0.39%
Manufacturers Life Insurance Company, The46,194$1.20M0.00%
TD Asset Management Inc44,782$1.07M0.00%
Soros Fund Management LLCSuperinvestorSoros Fund Management30,000$779.4K0.02%
Ghisallo Capital Management LLC30,000$779.4K0.04%
Teachers Retirement System of the State of Kentucky26,708$694.0K0.01%
Jane Street Group, LLC26,570$690.3K0.00%
Norges Bank25,000$649.5K0.00%
Point72 (DIFC) Ltd24,011$623.8K0.05%
Geode Capital Management, LLC22,269$578.5K0.00%
HRT Financial LP21,637$562.0K0.00%
Squarepoint Ops LLC16,470$427.9K0.00%
Barclays PLC16,400$426.1K0.00%
Point72 Asset Management, L.P.15,600$405.3K0.00%
Shay Capital LLC15,000$389.7K0.11%
Davidson Kempner Capital Management LP13,500$337.6K0.01%
Marshall Wace, LLP12,000$311.8K0.00%
Point72 Asia (Singapore) Pte. Ltd.10,706$278.1K0.05%
Capula Management Ltd8,362$217.2K0.00%
Sandia Investment Management LP5,000$129.9K0.21%
Legal & General Group Plc5,000$127.5K0.00%
Aster Capital Management (DIFC) Ltd1,810$47.0K0.01%
Tower Research Capital LLC (TRC)154$4.00K0.00%

Sold out (0)

Institutions that held MBX Biosciences, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

None.